HEADER CYTOKINE 29-OCT-23 8USR
TITLE IL17A HOMODIMER COMPLEXED TO COMPOUND 23
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: INTERLEUKIN-17A;
COMPND 3 CHAIN: A, B, C, D;
COMPND 4 SYNONYM: IL-17,IL-17A,CYTOTOXIC T-LYMPHOCYTE-ASSOCIATED ANTIGEN 8,
COMPND 5 CTLA-8;
COMPND 6 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 ORGANISM_TAXID: 9606;
SOURCE 5 GENE: IL17A, CTLA8, IL17;
SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI;
SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562
KEYWDS HOMODIMER, INHIBITOR, DEL, CYTOKINE
EXPDTA X-RAY DIFFRACTION
AUTHOR M.A.ARGIRIADI,A.L.RAMOS
REVDAT 4 13-NOV-24 8USR 1 REMARK
REVDAT 3 01-MAY-24 8USR 1 JRNL
REVDAT 2 17-APR-24 8USR 1 JRNL
REVDAT 1 03-APR-24 8USR 0
JRNL AUTH A.L.RAMOS,E.R.GOEDKEN,K.E.FRANK,M.A.ARGIRIADI,S.BAZZAZ,
JRNL AUTH 2 Z.BIAN,J.T.C.BROWN,P.A.CENTRELLA,H.J.CHEN,J.S.DISCH,
JRNL AUTH 3 P.L.DONNER,D.B.DUIGNAN,D.GIKUNJU,S.N.GRESZLER,M.A.GUIE,
JRNL AUTH 4 S.HABESHIAN,H.E.HARTL,C.D.HEIN,C.W.HUTCHINS,R.JETSON,
JRNL AUTH 5 A.D.KEEFE,H.KHAN,H.Q.LI,A.OLSZEWSKI,B.J.ORTIZ CARDONA,
JRNL AUTH 6 A.OSUMA,S.C.PANCHAL,R.PHELAN,W.QIU,J.B.SHOTWELL,A.SHRESTHA,
JRNL AUTH 7 M.SRIKUMARAN,Z.SU,C.SUN,A.K.UPADHYAY,M.D.WOOD,H.WU,R.ZHANG,
JRNL AUTH 8 Y.ZHANG,G.ZHAO,H.ZHU,M.P.WEBSTER
JRNL TITL DISCOVERY OF SMALL MOLECULE INTERLEUKIN 17A INHIBITORS WITH
JRNL TITL 2 NOVEL BINDING MODE AND STOICHIOMETRY: OPTIMIZATION OF
JRNL TITL 3 DNA-ENCODED CHEMICAL LIBRARY HITS TO IN VIVO ACTIVE
JRNL TITL 4 COMPOUNDS.
JRNL REF J.MED.CHEM. V. 67 6456 2024
JRNL REFN ISSN 0022-2623
JRNL PMID 38574366
JRNL DOI 10.1021/ACS.JMEDCHEM.3C02397
REMARK 2
REMARK 2 RESOLUTION. 1.83 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : PHENIX 1.19.2_4158
REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN
REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE,
REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER,
REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY,
REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON,
REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI,
REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT
REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART
REMARK 3
REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.83
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 32.59
REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350
REMARK 3 COMPLETENESS FOR RANGE (%) : 80.4
REMARK 3 NUMBER OF REFLECTIONS : 38008
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 R VALUE (WORKING + TEST SET) : 0.222
REMARK 3 R VALUE (WORKING SET) : 0.220
REMARK 3 FREE R VALUE : 0.250
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.130
REMARK 3 FREE R VALUE TEST SET COUNT : 1949
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS).
REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE
REMARK 3 1 32.5900 - 4.4100 1.00 3386 180 0.2088 0.2111
REMARK 3 2 4.4000 - 3.5000 1.00 3272 161 0.1810 0.1919
REMARK 3 3 3.5000 - 3.0600 1.00 3232 153 0.2019 0.2633
REMARK 3 4 3.0600 - 2.7800 0.99 3187 183 0.2160 0.2470
REMARK 3 5 2.7800 - 2.5800 0.94 2985 168 0.2296 0.2718
REMARK 3 6 2.5800 - 2.4300 0.99 3155 186 0.2417 0.2844
REMARK 3 7 2.4300 - 2.3000 0.99 3153 177 0.2494 0.3039
REMARK 3 8 2.3000 - 2.2000 0.88 2808 141 0.2614 0.2780
REMARK 3 9 2.2000 - 2.1200 0.98 3112 166 0.2794 0.3232
REMARK 3 10 2.1200 - 2.0500 0.81 2545 147 0.3080 0.3808
REMARK 3 11 2.0500 - 1.9800 0.86 2691 162 0.3188 0.3778
REMARK 3 12 1.9800 - 1.9300 0.58 1854 95 0.3264 0.3583
REMARK 3 13 1.9300 - 1.8800 0.16 432 17 0.3839 0.5395
REMARK 3 14 1.8700 - 1.8300 0.08 247 13 0.3984 0.4836
REMARK 3
REMARK 3 BULK SOLVENT MODELLING.
REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL
REMARK 3 SOLVENT RADIUS : 1.11
REMARK 3 SHRINKAGE RADIUS : 0.90
REMARK 3 K_SOL : NULL
REMARK 3 B_SOL : NULL
REMARK 3
REMARK 3 ERROR ESTIMATES.
REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.225
REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 31.769
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : 34.05
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 36.58
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : NULL
REMARK 3 B22 (A**2) : NULL
REMARK 3 B33 (A**2) : NULL
REMARK 3 B12 (A**2) : NULL
REMARK 3 B13 (A**2) : NULL
REMARK 3 B23 (A**2) : NULL
REMARK 3
REMARK 3 TWINNING INFORMATION.
REMARK 3 FRACTION: NULL
REMARK 3 OPERATOR: NULL
REMARK 3
REMARK 3 DEVIATIONS FROM IDEAL VALUES.
REMARK 3 RMSD COUNT
REMARK 3 BOND : 0.007 3282
REMARK 3 ANGLE : 1.133 4490
REMARK 3 CHIRALITY : 0.066 483
REMARK 3 PLANARITY : 0.007 622
REMARK 3 DIHEDRAL : 5.450 459
REMARK 3
REMARK 3 TLS DETAILS
REMARK 3 NUMBER OF TLS GROUPS : NULL
REMARK 3
REMARK 3 NCS DETAILS
REMARK 3 NUMBER OF NCS GROUPS : NULL
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4
REMARK 4 8USR COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 30-OCT-23.
REMARK 100 THE DEPOSITION ID IS D_1000278225.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 30-JAN-19
REMARK 200 TEMPERATURE (KELVIN) : 100
REMARK 200 PH : NULL
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : APS
REMARK 200 BEAMLINE : 17-ID
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 1.00
REMARK 200 MONOCHROMATOR : NULL
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : PIXEL
REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : AUTOPROC
REMARK 200 DATA SCALING SOFTWARE : AUTOPROC
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 45560
REMARK 200 RESOLUTION RANGE HIGH (A) : 1.830
REMARK 200 RESOLUTION RANGE LOW (A) : 79.500
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 80.7
REMARK 200 DATA REDUNDANCY : 5.700
REMARK 200 R MERGE (I) : NULL
REMARK 200 R SYM (I) : 0.12000
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 7.4000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.83
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.96
REMARK 200 COMPLETENESS FOR SHELL (%) : NULL
REMARK 200 DATA REDUNDANCY IN SHELL : NULL
REMARK 200 R MERGE FOR SHELL (I) : NULL
REMARK 200 R SYM FOR SHELL (I) : 1.19300
REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: PHASER
REMARK 200 STARTING MODEL: NULL
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 45.97
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.28
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 2 M NACL, 0.1 M NAH2PO4, 0.1 M KH2PO4,
REMARK 280 0.1 M MES PH 6.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 290K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X,-Y,Z+1/2
REMARK 290 3555 -X,Y,-Z+1/2
REMARK 290 4555 X,-Y,-Z
REMARK 290 5555 X+1/2,Y+1/2,Z
REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2
REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2
REMARK 290 8555 X+1/2,-Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 53.59000
REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 53.59000
REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000
REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 31.05500
REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 79.54500
REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 31.05500
REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 79.54500
REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 53.59000
REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 31.05500
REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 79.54500
REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 53.59000
REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 31.05500
REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 79.54500
REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1, 2
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 TOTAL BURIED SURFACE AREA: 4730 ANGSTROM**2
REMARK 350 SURFACE AREA OF THE COMPLEX: 10370 ANGSTROM**2
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -26.0 KCAL/MOL
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 350
REMARK 350 BIOMOLECULE: 2
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 TOTAL BURIED SURFACE AREA: 4600 ANGSTROM**2
REMARK 350 SURFACE AREA OF THE COMPLEX: 10250 ANGSTROM**2
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -26.0 KCAL/MOL
REMARK 350 APPLY THE FOLLOWING TO CHAINS: C
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 350 APPLY THE FOLLOWING TO CHAINS: D
REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 -53.59000
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 GLY A 29
REMARK 465 SER A 30
REMARK 465 ALA A 31
REMARK 465 MET A 32
REMARK 465 ALA A 33
REMARK 465 PRO A 34
REMARK 465 ASN A 35
REMARK 465 SER A 36
REMARK 465 GLU A 37
REMARK 465 ASP A 38
REMARK 465 LYS A 39
REMARK 465 ASN A 40
REMARK 465 ILE A 51
REMARK 465 HIS A 52
REMARK 465 ASN A 53
REMARK 465 ARG A 54
REMARK 465 ASN A 55
REMARK 465 THR A 56
REMARK 465 ASN A 57
REMARK 465 THR A 58
REMARK 465 ASN A 59
REMARK 465 PRO A 60
REMARK 465 LYS A 61
REMARK 465 ARG A 62
REMARK 465 SER A 63
REMARK 465 ILE A 150
REMARK 465 VAL A 151
REMARK 465 HIS A 152
REMARK 465 HIS A 153
REMARK 465 VAL A 154
REMARK 465 ALA A 155
REMARK 465 GLY B 29
REMARK 465 SER B 30
REMARK 465 ALA B 31
REMARK 465 MET B 32
REMARK 465 ALA B 33
REMARK 465 PRO B 34
REMARK 465 ASN B 35
REMARK 465 SER B 36
REMARK 465 GLU B 37
REMARK 465 ASP B 38
REMARK 465 LYS B 39
REMARK 465 ASN B 40
REMARK 465 PHE B 41
REMARK 465 PRO B 42
REMARK 465 ARG B 43
REMARK 465 ARG B 54
REMARK 465 ASN B 55
REMARK 465 THR B 56
REMARK 465 ASN B 57
REMARK 465 THR B 58
REMARK 465 ASN B 59
REMARK 465 PRO B 60
REMARK 465 LYS B 61
REMARK 465 ARG B 62
REMARK 465 SER B 63
REMARK 465 ILE B 150
REMARK 465 VAL B 151
REMARK 465 HIS B 152
REMARK 465 HIS B 153
REMARK 465 VAL B 154
REMARK 465 ALA B 155
REMARK 465 GLY C 29
REMARK 465 SER C 30
REMARK 465 ALA C 31
REMARK 465 MET C 32
REMARK 465 ALA C 33
REMARK 465 PRO C 34
REMARK 465 ASN C 35
REMARK 465 SER C 36
REMARK 465 GLU C 37
REMARK 465 ASP C 38
REMARK 465 LYS C 39
REMARK 465 ASN C 40
REMARK 465 PHE C 41
REMARK 465 HIS C 52
REMARK 465 ASN C 53
REMARK 465 ARG C 54
REMARK 465 ASN C 55
REMARK 465 THR C 56
REMARK 465 ASN C 57
REMARK 465 THR C 58
REMARK 465 ASN C 59
REMARK 465 PRO C 60
REMARK 465 LYS C 61
REMARK 465 ARG C 62
REMARK 465 SER C 63
REMARK 465 VAL C 151
REMARK 465 HIS C 152
REMARK 465 HIS C 153
REMARK 465 VAL C 154
REMARK 465 ALA C 155
REMARK 465 GLY D 29
REMARK 465 SER D 30
REMARK 465 ALA D 31
REMARK 465 MET D 32
REMARK 465 ALA D 33
REMARK 465 PRO D 34
REMARK 465 ASN D 35
REMARK 465 SER D 36
REMARK 465 GLU D 37
REMARK 465 ASP D 38
REMARK 465 LYS D 39
REMARK 465 ASN D 40
REMARK 465 PHE D 41
REMARK 465 PRO D 42
REMARK 465 ARG D 43
REMARK 465 ILE D 51
REMARK 465 HIS D 52
REMARK 465 ASN D 53
REMARK 465 ARG D 54
REMARK 465 ASN D 55
REMARK 465 THR D 56
REMARK 465 ASN D 57
REMARK 465 THR D 58
REMARK 465 ASN D 59
REMARK 465 PRO D 60
REMARK 465 LYS D 61
REMARK 465 ARG D 62
REMARK 465 SER D 63
REMARK 465 ILE D 150
REMARK 465 VAL D 151
REMARK 465 HIS D 152
REMARK 465 HIS D 153
REMARK 465 VAL D 154
REMARK 465 ALA D 155
REMARK 470
REMARK 470 MISSING ATOM
REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER;
REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER;
REMARK 470 I=INSERTION CODE):
REMARK 470 M RES CSSEQI ATOMS
REMARK 470 PHE A 41 CG CD1 CD2 CE1 CE2 CZ
REMARK 470 LYS A 93 CG CD CE NZ
REMARK 470 LYS B 93 CG CD CE NZ
REMARK 470 ARG B 134 CG CD NE CZ NH1 NH2
REMARK 470 ARG C 43 CG CD NE CZ NH1 NH2
REMARK 470 ARG C 123 CG CD NE CZ NH1 NH2
REMARK 470 HIS D 77 CG ND1 CD2 CE1 NE2
REMARK 470 LYS D 93 CG CD CE NZ
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT
REMARK 500
REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT.
REMARK 500
REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE
REMARK 500 OE1 GLU A 125 O HOH A 301 2.02
REMARK 500 O HOH A 354 O HOH D 350 2.18
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 ASP B 65 42.73 -72.18
REMARK 500 SER B 72 71.47 -117.19
REMARK 500 HIS B 128 -3.28 75.19
REMARK 500 ASP C 65 24.36 -77.60
REMARK 500 SER C 72 70.60 -119.59
REMARK 500 ASN C 131 15.08 -140.55
REMARK 500 SER D 72 69.76 -118.76
REMARK 500 HIS D 128 -3.41 69.45
REMARK 500
REMARK 500 REMARK: NULL
REMARK 525
REMARK 525 SOLVENT
REMARK 525
REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT
REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST
REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT
REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE
REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER;
REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE
REMARK 525 NUMBER; I=INSERTION CODE):
REMARK 525
REMARK 525 M RES CSSEQI
REMARK 525 HOH C 261 DISTANCE = 6.79 ANGSTROMS
REMARK 525 HOH D 355 DISTANCE = 6.04 ANGSTROMS
DBREF 8USR A 34 155 UNP Q16552 IL17_HUMAN 34 155
DBREF 8USR B 34 155 UNP Q16552 IL17_HUMAN 34 155
DBREF 8USR C 34 155 UNP Q16552 IL17_HUMAN 34 155
DBREF 8USR D 34 155 UNP Q16552 IL17_HUMAN 34 155
SEQADV 8USR GLY A 29 UNP Q16552 EXPRESSION TAG
SEQADV 8USR SER A 30 UNP Q16552 EXPRESSION TAG
SEQADV 8USR ALA A 31 UNP Q16552 EXPRESSION TAG
SEQADV 8USR MET A 32 UNP Q16552 EXPRESSION TAG
SEQADV 8USR ALA A 33 UNP Q16552 EXPRESSION TAG
SEQADV 8USR SER A 129 UNP Q16552 CYS 129 ENGINEERED MUTATION
SEQADV 8USR GLY B 29 UNP Q16552 EXPRESSION TAG
SEQADV 8USR SER B 30 UNP Q16552 EXPRESSION TAG
SEQADV 8USR ALA B 31 UNP Q16552 EXPRESSION TAG
SEQADV 8USR MET B 32 UNP Q16552 EXPRESSION TAG
SEQADV 8USR ALA B 33 UNP Q16552 EXPRESSION TAG
SEQADV 8USR SER B 129 UNP Q16552 CYS 129 ENGINEERED MUTATION
SEQADV 8USR GLY C 29 UNP Q16552 EXPRESSION TAG
SEQADV 8USR SER C 30 UNP Q16552 EXPRESSION TAG
SEQADV 8USR ALA C 31 UNP Q16552 EXPRESSION TAG
SEQADV 8USR MET C 32 UNP Q16552 EXPRESSION TAG
SEQADV 8USR ALA C 33 UNP Q16552 EXPRESSION TAG
SEQADV 8USR SER C 129 UNP Q16552 CYS 129 ENGINEERED MUTATION
SEQADV 8USR GLY D 29 UNP Q16552 EXPRESSION TAG
SEQADV 8USR SER D 30 UNP Q16552 EXPRESSION TAG
SEQADV 8USR ALA D 31 UNP Q16552 EXPRESSION TAG
SEQADV 8USR MET D 32 UNP Q16552 EXPRESSION TAG
SEQADV 8USR ALA D 33 UNP Q16552 EXPRESSION TAG
SEQADV 8USR SER D 129 UNP Q16552 CYS 129 ENGINEERED MUTATION
SEQRES 1 A 127 GLY SER ALA MET ALA PRO ASN SER GLU ASP LYS ASN PHE
SEQRES 2 A 127 PRO ARG THR VAL MET VAL ASN LEU ASN ILE HIS ASN ARG
SEQRES 3 A 127 ASN THR ASN THR ASN PRO LYS ARG SER SER ASP TYR TYR
SEQRES 4 A 127 ASN ARG SER THR SER PRO TRP ASN LEU HIS ARG ASN GLU
SEQRES 5 A 127 ASP PRO GLU ARG TYR PRO SER VAL ILE TRP GLU ALA LYS
SEQRES 6 A 127 CYS ARG HIS LEU GLY CYS ILE ASN ALA ASP GLY ASN VAL
SEQRES 7 A 127 ASP TYR HIS MET ASN SER VAL PRO ILE GLN GLN GLU ILE
SEQRES 8 A 127 LEU VAL LEU ARG ARG GLU PRO PRO HIS SER PRO ASN SER
SEQRES 9 A 127 PHE ARG LEU GLU LYS ILE LEU VAL SER VAL GLY CYS THR
SEQRES 10 A 127 CYS VAL THR PRO ILE VAL HIS HIS VAL ALA
SEQRES 1 B 127 GLY SER ALA MET ALA PRO ASN SER GLU ASP LYS ASN PHE
SEQRES 2 B 127 PRO ARG THR VAL MET VAL ASN LEU ASN ILE HIS ASN ARG
SEQRES 3 B 127 ASN THR ASN THR ASN PRO LYS ARG SER SER ASP TYR TYR
SEQRES 4 B 127 ASN ARG SER THR SER PRO TRP ASN LEU HIS ARG ASN GLU
SEQRES 5 B 127 ASP PRO GLU ARG TYR PRO SER VAL ILE TRP GLU ALA LYS
SEQRES 6 B 127 CYS ARG HIS LEU GLY CYS ILE ASN ALA ASP GLY ASN VAL
SEQRES 7 B 127 ASP TYR HIS MET ASN SER VAL PRO ILE GLN GLN GLU ILE
SEQRES 8 B 127 LEU VAL LEU ARG ARG GLU PRO PRO HIS SER PRO ASN SER
SEQRES 9 B 127 PHE ARG LEU GLU LYS ILE LEU VAL SER VAL GLY CYS THR
SEQRES 10 B 127 CYS VAL THR PRO ILE VAL HIS HIS VAL ALA
SEQRES 1 C 127 GLY SER ALA MET ALA PRO ASN SER GLU ASP LYS ASN PHE
SEQRES 2 C 127 PRO ARG THR VAL MET VAL ASN LEU ASN ILE HIS ASN ARG
SEQRES 3 C 127 ASN THR ASN THR ASN PRO LYS ARG SER SER ASP TYR TYR
SEQRES 4 C 127 ASN ARG SER THR SER PRO TRP ASN LEU HIS ARG ASN GLU
SEQRES 5 C 127 ASP PRO GLU ARG TYR PRO SER VAL ILE TRP GLU ALA LYS
SEQRES 6 C 127 CYS ARG HIS LEU GLY CYS ILE ASN ALA ASP GLY ASN VAL
SEQRES 7 C 127 ASP TYR HIS MET ASN SER VAL PRO ILE GLN GLN GLU ILE
SEQRES 8 C 127 LEU VAL LEU ARG ARG GLU PRO PRO HIS SER PRO ASN SER
SEQRES 9 C 127 PHE ARG LEU GLU LYS ILE LEU VAL SER VAL GLY CYS THR
SEQRES 10 C 127 CYS VAL THR PRO ILE VAL HIS HIS VAL ALA
SEQRES 1 D 127 GLY SER ALA MET ALA PRO ASN SER GLU ASP LYS ASN PHE
SEQRES 2 D 127 PRO ARG THR VAL MET VAL ASN LEU ASN ILE HIS ASN ARG
SEQRES 3 D 127 ASN THR ASN THR ASN PRO LYS ARG SER SER ASP TYR TYR
SEQRES 4 D 127 ASN ARG SER THR SER PRO TRP ASN LEU HIS ARG ASN GLU
SEQRES 5 D 127 ASP PRO GLU ARG TYR PRO SER VAL ILE TRP GLU ALA LYS
SEQRES 6 D 127 CYS ARG HIS LEU GLY CYS ILE ASN ALA ASP GLY ASN VAL
SEQRES 7 D 127 ASP TYR HIS MET ASN SER VAL PRO ILE GLN GLN GLU ILE
SEQRES 8 D 127 LEU VAL LEU ARG ARG GLU PRO PRO HIS SER PRO ASN SER
SEQRES 9 D 127 PHE ARG LEU GLU LYS ILE LEU VAL SER VAL GLY CYS THR
SEQRES 10 D 127 CYS VAL THR PRO ILE VAL HIS HIS VAL ALA
HET XCE A 201 56
HET XCE A 202 56
HET XCE D 201 56
HET XCE D 202 56
HETNAM XCE ~{N}-[(2~{S})-1-[[(1~{S})-1-(8~{A}~{H}-IMIDAZO[1,2-
HETNAM 2 XCE A]PYRIMIDIN-2-YL)ETHYL]AMINO]-1-OXIDANYLIDENE-4-
HETNAM 3 XCE PHENYL-BUTAN-2-YL]-4,5-BIS(CHLORANYL)-1~{H}-PYRROLE-2-
HETNAM 4 XCE CARBOXAMIDE
FORMUL 5 XCE 4(C23 H22 CL2 N6 O2)
FORMUL 9 HOH *216(H2 O)
HELIX 1 AA1 ASP A 65 SER A 70 1 6
HELIX 2 AA2 ASP B 65 SER B 70 1 6
HELIX 3 AA3 ASP C 65 SER C 70 1 6
HELIX 4 AA4 ASP D 65 SER D 70 1 6
SHEET 1 AA1 8 ARG A 84 TYR A 85 0
SHEET 2 AA1 8 ASN A 111 ARG A 124 -1 O LEU A 122 N TYR A 85
SHEET 3 AA1 8 SER A 132 VAL A 147 -1 O GLY A 143 N ILE A 115
SHEET 4 AA1 8 VAL B 45 HIS B 52 1 O ASN B 48 N LEU A 135
SHEET 5 AA1 8 THR A 44 ASN A 48 -1 N VAL A 45 O VAL B 47
SHEET 6 AA1 8 SER B 132 VAL B 147 1 O LEU B 135 N ASN A 48
SHEET 7 AA1 8 ASN B 111 ARG B 124 -1 N ILE B 115 O GLY B 143
SHEET 8 AA1 8 ARG B 84 TYR B 85 -1 N TYR B 85 O LEU B 122
SHEET 1 AA2 2 TRP A 74 GLU A 80 0
SHEET 2 AA2 2 VAL A 88 CYS A 94 -1 O GLU A 91 N HIS A 77
SHEET 1 AA3 2 CYS A 99 ILE A 100 0
SHEET 2 AA3 2 VAL A 106 ASP A 107 -1 O ASP A 107 N CYS A 99
SHEET 1 AA4 2 TRP B 74 GLU B 80 0
SHEET 2 AA4 2 VAL B 88 CYS B 94 -1 O LYS B 93 N ASN B 75
SHEET 1 AA5 2 CYS B 99 ILE B 100 0
SHEET 2 AA5 2 VAL B 106 ASP B 107 -1 O ASP B 107 N CYS B 99
SHEET 1 AA6 2 TRP C 74 GLU C 80 0
SHEET 2 AA6 2 VAL C 88 CYS C 94 -1 O LYS C 93 N ASN C 75
SHEET 1 AA7 3 ARG C 84 TYR C 85 0
SHEET 2 AA7 3 ASN C 111 ARG C 124 -1 O LEU C 122 N TYR C 85
SHEET 3 AA7 3 PHE C 133 VAL C 147 -1 O ARG C 134 N ARG C 123
SHEET 1 AA8 2 CYS C 99 ILE C 100 0
SHEET 2 AA8 2 VAL C 106 ASP C 107 -1 O ASP C 107 N CYS C 99
SHEET 1 AA9 2 TRP D 74 GLU D 80 0
SHEET 2 AA9 2 VAL D 88 CYS D 94 -1 O GLU D 91 N HIS D 77
SHEET 1 AB1 3 ARG D 84 TYR D 85 0
SHEET 2 AB1 3 ASN D 111 ARG D 124 -1 O LEU D 122 N TYR D 85
SHEET 3 AB1 3 PHE D 133 VAL D 147 -1 O GLY D 143 N ILE D 115
SHEET 1 AB2 2 CYS D 99 ILE D 100 0
SHEET 2 AB2 2 VAL D 106 ASP D 107 -1 O ASP D 107 N CYS D 99
SSBOND 1 CYS A 94 CYS A 144 1555 1555 2.08
SSBOND 2 CYS A 99 CYS A 146 1555 1555 2.04
SSBOND 3 CYS B 94 CYS B 144 1555 1555 2.08
SSBOND 4 CYS B 99 CYS B 146 1555 1555 2.06
SSBOND 5 CYS C 94 CYS C 144 1555 1555 2.10
SSBOND 6 CYS C 99 CYS C 146 1555 1555 2.04
SSBOND 7 CYS D 94 CYS D 144 1555 1555 2.07
SSBOND 8 CYS D 99 CYS D 146 1555 1555 2.05
CISPEP 1 TYR A 85 PRO A 86 0 -1.43
CISPEP 2 GLU A 125 PRO A 126 0 0.05
CISPEP 3 TYR B 85 PRO B 86 0 -5.92
CISPEP 4 GLU B 125 PRO B 126 0 -0.43
CISPEP 5 TYR C 85 PRO C 86 0 -4.64
CISPEP 6 GLU C 125 PRO C 126 0 -2.19
CISPEP 7 TYR D 85 PRO D 86 0 -0.29
CISPEP 8 GLU D 125 PRO D 126 0 -0.39
CRYST1 62.110 159.090 107.180 90.00 90.00 90.00 C 2 2 21 32
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.016100 0.000000 0.000000 0.00000
SCALE2 0.000000 0.006286 0.000000 0.00000
SCALE3 0.000000 0.000000 0.009330 0.00000